MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. - Wikidata - wikimedia - TriplyDB

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.

http://www.wikidata.org/entity/Q37715770

about

MicroRNA in rectal cancer MicroRNAs in colorectal carcinoma--from pathogenesis to therapy Studies of Tumor Suppressor Genes via Chromosome Engineering MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer Non-coding landscapes of colorectal cancer Mouse models of intestinal cancer Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer.Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway.Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling Deregulation of MicroRNAs in Gastric Lymphomagenesis Induced in the d3Tx Mouse Model of Helicobacter pylori Infection Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.Circulating miRNAs in cancer: from detection to therapy.MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma.miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance.Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer MicroRNA-23b Promotes Avian Leukosis Virus Subgroup J (ALV-J) Replication by Targeting IRF1.miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2.Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell proliferation and apoptosis.MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.How interacting pathways are regulated by miRNAs in breast cancer subtypes.PTEN regulates RPA1 and protects DNA replication forks.Distinct Profiles for Mitochondrial t-RNAs and Small Nucleolar RNAs in Locally Invasive and Metastatic Colorectal Cancer.The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN.miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.Colorectal cancer carcinogenesis: a review of mechanisms Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome Transient resistance to DNA damaging agents is associated with expression of microRNAs-135b and -196b in human leukemia cell lines.DDA1 promotes stage IIB-IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling.Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer.

P2860

Q26748754-FF2BE090-7496-47B9-8CD6-A89A59C6FCBC Q26766510-2721545B-D641-4431-B9EB-F52AD8A22149 Q26771240-5AC1EC08-DDCF-46DC-A13A-5AFD877574C9 Q26775610-29391B81-4C5D-489A-A5C9-0DFAFD29513F Q26778014-4B88A588-D73E-4C6E-9A25-D2CC692BEE60 Q26785563-C9EB4F77-ED71-4815-BBA9-B27D1DB560BF Q26796590-868AB9B8-1E6C-4E5A-9941-0FF59AF8A2FD Q26861185-203B0A88-8C54-4CB5-BE6F-93038E8E7220 Q30990997-483A13D6-0573-4A5C-A426-CE3FA282A0A4 Q33599015-E52024F2-EF33-4F50-BAC0-B1DC4D02EA76 Q33618440-BE57447B-05E7-4C5D-A6BC-0C644A0B7220 Q33650801-733A077F-16D2-4EFA-9251-FD2D765F4E0A Q33689752-BC40010D-D10B-4C16-B5D8-513DCFC4BE36 Q33720978-A1852727-8F54-4306-98F1-545850EB327B Q34728385-154D10FB-2C79-43C3-96DB-22CA7C34EEF3 Q35273709-130D6AD5-440B-4403-939D-5E96B1BB2FED Q35439100-02BC794A-9ED5-4E37-B62E-F73C0BA577A7 Q35536379-FA6A93EF-E33E-4732-B7B7-F686A5C0AB11 Q35587056-C9890DE0-67CA-4596-A7C8-A403A680B63F Q35616680-0C9BAB39-3199-47E7-9EC9-092C23BB287E Q35659745-413FB0FC-CAE5-469A-B39D-95BF9DE47284 Q35757995-0EBD88F8-B1C1-4D50-BEF8-FEDA058B7D2D Q35904200-0ED9F5CD-099D-4F07-9D63-77ED420A9C16 Q35946366-29A3658D-C274-4E7A-A0DC-6B89BE1EA31A Q36000232-3993F891-38C8-48E3-969A-6DBAEF5E923F Q36189343-6D75C046-07D3-4EA5-BB0C-207B54024481 Q36261352-EBBFEF49-E6C2-4050-A45B-2A8F4C6E5EBD Q36276533-55BA6E09-95C8-4421-9463-74BCA0D72CD7 Q36292984-558AE3FE-0D6A-443C-A312-E0182EF715FA Q36535386-9366B07D-D431-46F3-9185-69070E92AF41 Q36536455-AB7BEAF7-91A4-4B9E-A875-31E8C56569B6 Q36545707-0F89C1E8-0710-46CF-878B-783A66D85B2B Q36849645-75F08450-3B8E-4D5F-9E88-2EEC78D9AE4F Q36998156-44D78B2C-5B0D-46F1-A83C-8D90539D0A86 Q37168584-BD708050-E3D3-43FC-9A08-DA625728F7C3 Q37190177-CE9B4C11-8AAA-4BEF-87FB-ECE676C18B91 Q37268517-345126BE-F65F-48FC-993D-1B4E1222D1E0 Q37295716-B2CCD696-D9E4-4A30-9090-752963139D92 Q37317631-3A533815-76EE-4195-B8C3-CFB771C54CE2 Q37416261-3FF85973-0C09-4D9F-BE03-C7823EE9B68C

P2860

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.

http://www.wikidata.org/entity/Q37715770

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MicroRNA-135b promotes cancer ...... enic pathways in colon cancer.

@en

MicroRNA-135b promotes cancer ...... enic pathways in colon cancer.

@nl

type

label

MicroRNA-135b promotes cancer ...... enic pathways in colon cancer.

@en

MicroRNA-135b promotes cancer ...... enic pathways in colon cancer.

@nl

prefLabel

MicroRNA-135b promotes cancer ...... enic pathways in colon cancer.

@en

MicroRNA-135b promotes cancer ...... enic pathways in colon cancer.

@nl

P1433

Q37715770-4674D54C-06EE-49F6-98D5-65F1DA15EB30

P1476

Q37715770-5A770821-0F66-45A7-A870-8C162BAD65B4

P2093

Q37715770-314D08FE-1052-4642-B240-9ABDC233B9B9

Q37715770-3C968675-9BA2-423E-8EC2-FF6425688B84

Q37715770-4621169B-1433-4B12-9E36-8AA7240A821E

Q37715770-50693B23-5F89-4ADF-BF2C-89F3BA7FAF34

Q37715770-56515011-AA48-444B-8A2F-8DF31842799C

Q37715770-582E93E3-D8D3-438F-882E-693FFF70F7B1

Q37715770-5BE7690B-6853-4398-A631-2DD83307E4A6

Q37715770-820C980F-E7DE-46D9-ADBA-783BBC5FF4EF

Q37715770-94B64F7A-B35C-47C5-AC8B-9E413502286F

Q37715770-9B08484B-B9F6-4F94-844E-E0F70A14A992

P2860

Q37715770-021904DA-75F1-40AB-97F1-3095B8B0DA7E

Q37715770-0467CA07-AB5A-4669-90D2-99CBEC351B7B

Q37715770-11D428A7-70DC-4027-979E-EC0CA0E962C2

Q37715770-1C006C16-0822-4C13-8741-84190435DA04

Q37715770-1D0CF968-94AD-4E20-9C87-D058D2A2F0B3

Q37715770-1F4DFC56-FEFC-4985-972C-7E55F6930CDA

Q37715770-232C371A-807C-4073-9CFA-73D611881901

Q37715770-32374C6B-389A-4897-9A52-513BBD0CF774

Q37715770-34CEFB7B-EB3C-4A69-9E01-D84C5F460BF6

Q37715770-367AB7AC-6514-4DC6-BC9C-FCB3B6EC9BEF

P304

Q37715770-4A9C273B-F7EA-4DF7-8431-3E9F9FFC7EF2

P31

Q37715770-A161D050-619F-410A-A997-0A521AFA74A7

P356

Q37715770-AFEA48C5-7426-4069-8E65-ECF9479C6D51

P433

Q37715770-25917CFA-6288-4546-8760-BEC871A4F38B

P478

Q37715770-192DF279-681E-493F-94EC-69F9C0801045

P50

Q37715770-55AEC972-2F28-4707-B8DB-53247807547A

Q37715770-64A63567-C834-43A4-8958-013F6A27A72E

Q37715770-68C00307-C8AB-417D-AD9A-67FAB865A637

Q37715770-734718BC-432C-4C8C-A6DA-0DBF2D722C24

Q37715770-758D7B00-1308-4B5A-9A00-96E239F25F0D

Q37715770-7866046B-3F22-4818-972E-A75E7D22FD9D

Q37715770-8A3E3E6B-9007-4AD8-B43D-D717E951D745

Q37715770-9A2F18D3-0ADD-496F-9280-8DAAAAA6EEA6

Q37715770-9BF92066-565A-4DB4-8186-2660CA566429

Q37715770-A7CB158F-A4A7-40D2-B9FA-1161DEE85A6D

P577

Q37715770-1DE60D8F-58A6-4A36-BCCA-504C69530CB3

P5875

Q37715770-45C01CE2-0E0B-4DD7-89C0-A561EEC22FDA

P698

Q37715770-CE455F1B-C87D-4ABE-867D-CD7B613217EE

P921

Q37715770-3F727023-D3D3-470B-B85B-45E3BC7D877A

P932

Q37715770-A6C3F155-AF6B-4680-8B10-89C0507EC736

P356

J.CCR.2014.03.006

P1433

P1476

MicroRNA-135b promotes cancer ...... enic pathways in colon cancer.

@en

P2093

Alessio Paone

http://www.w3.org/2001/XMLSchema#string

Claudio Murgia

http://www.w3.org/2001/XMLSchema#string

Francesca Lovat

http://www.w3.org/2001/XMLSchema#string

Gerard J Nuovo

http://www.w3.org/2001/XMLSchema#string

Giovanni Lanza

http://www.w3.org/2001/XMLSchema#string

Hansjuerg Alder

http://www.w3.org/2001/XMLSchema#string

Joanna Groden

http://www.w3.org/2001/XMLSchema#string

Khlea M Sumani

http://www.w3.org/2001/XMLSchema#string

Lynn Ueno

http://www.w3.org/2001/XMLSchema#string

Mary P Moyer

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer

FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity

Fast and effective prediction of microRNA/target duplexes

Modulation of mismatch repair and genomic stability by miR-155

Comprehensive molecular characterization of human colon and rectal cancer

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

Prediction of mammalian microRNA targets

The consensus coding sequences of human breast and colorectal cancers

Causes and consequences of microRNA dysregulation in cancer

P304

469-483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2014.03.006

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Angelo Veronese

Jonathan Ross Hart

Julia B Cordero

Luciano Cascione

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261741303

http://www.w3.org/2001/XMLSchema#string

P698

24735923

http://www.w3.org/2001/XMLSchema#string

P921

P932

3995091

http://www.w3.org/2001/XMLSchema#string